| Current Price | $31.47 | Mkt Cap | $8.64B |
|---|---|---|---|
| Open | $31.37 | P/E Ratio | 7.80 |
| Prev. Close | $31.53 | Div. (Yield) | N/A (N/A) |
| Daily Range | $31.16 - $31.56 | Volume | 1,093,973 |
| 52-Wk Range | $28.47 - $40.52 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- S&P 500 Analyst Estimate Revisions for Feb. 10 2/10/2012 8:14:27 AM -
- Greek Doctors Battle Hospital Superbug 2/9/2012 5:01:00 PM -
- Market Report -- In Play (FRX) 2/8/2012 2:33:00 AM -
- Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 2/8/2012 2:00:00 AM -
- Positive Results on Forest/Gedeon Drug - Analyst Blog 2/9/2012 6:33:01 PM
- The Zacks Analyst Blog Highlights: Citigroup, JPMorgan Chase, Goldman Sachs Group, Bank of America a 1/18/2012 8:30:01 AM
- Forest Laboratories Beats Analyst Estimates on EPS 1/17/2012 1:47:11 PM
- Forest Laboratories Beats Analyst Estimates on EPS 1/17/2012 1:47:11 PM
| Subject | Recs | Author | Date |
|---|



